RNF145
RING finger protein 145
Also known as: FLJ31951, RN145_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96MT1
- Gene
- RNF145
- Ensembl
- ENSG00000145860
- Chromosome
- 5
- Canonical length
- 663 aa
- Protein class
- Enzymes, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ERAD pathway and proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in endomembrane system. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
663 residues, UniProt reviewed canonical sequence.
>Q96MT1|RNF145
1 MAAKEKLEAV LNVALRVPSI MLLDVLYRWD VSSFFQQIQR SSLSNNPLFQ YKYLALNMHY
61 VGYILSVVLL TLPRQHLVQL YLYFLTALLL YAGHQISRDY VRSELEFAYE GPMYLEPLSM
121 NRFTTALIGQ LVVCTLCSCV MKTKQIWLFS AHMLPLLARL CLVPLETIVI INKFAMIFTG
181 LEVLYFLGSN LLVPYNLAKS AYRELVQVVE VYGLLALGMS LWNQLVVPVL FMVFWLVLFA
241 LQIYSYFSTR DQPASRERLL FLFLTSIAEC CSTPYSLLGL VFTVSFVALG VLTLCKFYLQ
301 GYRAFMNDPA MNRGMTEGVT LLILAVQTGL IELQVVHRAF LLSIILFIVV ASILQSMLEI
361 ADPIVLALGA SRDKSLWKHF RAVSLCLFLL VFPAYMAYMI CQFFHMDFWL LIIISSSILT
421 SLQVLGTLFI YVLFMVEEFR KEPVENMDDV IYYVNGTYRL LEFLVALCVV AYGVSETIFG
481 EWTVMGSMII FIHSYYNVWL RAQLGWKSFL LRRDAVNKIK SLPIATKEQL EKHNDICAIC
541 YQDMKSAVIT PCSHFFHAGC LKKWLYVQET CPLCHCHLKN SSQLPGLGTE PVLQPHAGAE
601 QNVMFQEGTE PPGQEHTPGT RIQEGSRDNN EYIARRPDNQ EGAFDPKEYP HSAKDEAHPV
661 ESALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF145 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 14
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- lung: 69 nTPM
- urinary bladder: 64 nTPM
- esophagus: 50 nTPM
- placenta: 49 nTPM
- tonsil: 45 nTPM
- gallbladder: 45 nTPM
Single-cell type
- alveolar cells type 2: 665 nCPM
- transitional alveolar cells: 607 nCPM
- breast lactating cells: 479 nCPM
- neutrophil progenitors: 419 nCPM
- neutrophils: 418 nCPM
- esophageal apical cells: 363 nCPM
Immune cell
- eosinophil: 16 nTPM
- memory B-cell: 11 nTPM
- neutrophil: 9.5 nTPM
- T-reg: 6.3 nTPM
- naive CD4 T-cell: 5.9 nTPM
- naive B-cell: 5.2 nTPM
Brain region
- hypothalamus: 48 nTPM
- choroid plexus: 45 nTPM
- cerebellum: 39 nTPM
- basal ganglia: 38 nTPM
- cerebral cortex: 38 nTPM
- white matter: 36 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.31
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 3.59
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNF145 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF145 as an antibody target. Whether an autoantibody or antibody against RNF145 could matter depends on whether native RNF145 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF145 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF145 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...